Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J Vermylen

MK-383 (L-700,462), a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, Is Active in Man

Circulation
Cardiovascular MedicinePhysiologyCardiology
1993English

Effectiveness and Tolerability of CV-3988, a Selective PAF Antagonist, After Intravenous Administration to Man.

British Journal of Clinical Pharmacology
Pharmacology
1988English

Related publications

Platelet Inhibition After Glycoprotein IIb/IIIa Inhibitor Therapy

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Deaths Associated With Platelet Glycoprotein IIb/IIIa Inhibitor Treatment

Heart
2003English

Platelet Inhibition With an Antibody to Glycoprotein IIb/IIIa

Circulation
Cardiovascular MedicinePhysiologyCardiology
1989English

Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?

Frontiers in Physiology
Physiology
2018English

Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

JAMA - Journal of the American Medical Association
Medicine
2000English

Role of Platelet Membrane Glycoprotein IIb-IIIa in Agonist-Induced Tyrosine Phosphorylation of Platelet Proteins

Journal of Cell Biology
MedicineCell Biology
1990English

Glycoprotein IIb/IIIa Induced Coronary Thrombolysis

Heart
2002English

Platelet Glycoprotein IIb/IIIa Inhibition and Atheroembolism During Bypass Graft Angioplasty: A Cup Half Full

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Off-Target Effects of Glycoprotein IIb/IIIa Receptor Inhibitors

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy